E-LIB Suche - Ergebnisse für: Daver, G.

1

Postcranial evidence of late Miocene hominin bipedalism in ..:

Daver, G. ; Guy, F. ; Mackaye, H. T....
Nature. 609 (2022) 7925 - p. 94-100 , 2022

2

Biomechanical analysis of lithic tools production: impact o..:

Macchi, R. ; Daver, G. ; Brenet, M....
Computer Methods in Biomechanics and Biomedical Engineering. 22 (2019) sup1 - p. S521-S522 , 2019

Link: https://doi.org/10.1080/..

3

Morphological Variability in Paleoanthropology: New Approac..:

Daver, G. ; Balzeau, A. ; Berillon, G..
Bulletins et Mémoires de la Société d'Anthropologie de Paris. 31 (2019) 1-2 - p. 1-4 , 2019

Link: https://doi.org/10.3166/..

4

Fossil hominins, quadrupedal primates and the origin of hum..:

Daver, G. ; Détroit, F. ; Berillon, G...
BMSAP. 26 (2014) 3-4 - p. 121-128 , 2014

Link: https://doi.org/10.1007/..

5

Primates non humains : bilan des recherches et perspectives..:

Berillon, G. ; Daver, G.
BMSAP. 26 (2014) 3-4 - p. 103-104 , 2014

Link: https://doi.org/10.1007/..

6

Pivekimab sunirine (IMGN632), a novel CD123-targeting antib..:

Daver, Naval G ; Montesinos, Pau ; DeAngelo, Daniel J...
The Lancet Oncology. 25 (2024) 3 - p. 388-399 , 2024

Link: https://doi.org/10.1016/..

7

Characteristics and outcomes of acute myeloid leukaemia pat..:

Jen, Wei‐Ying ; Sasaki, Koji ; Loghavi, Sanam...
British Journal of Haematology. 204 (2024) 6 - p. 2259-2263 , 2024

Link: https://doi.org/10.1111/..

8

Sotatercept for anemia of myelofibrosis: a phase II investi..:

Bose, Prithviraj ; Masarova, Lucia ; Pemmaraju, Naveen...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

9

Prognostic risk signature in patients with acute myeloid le..:

Bataller, Alex ; Bazinet, Alexandre ; DiNardo, Courtney D....
Blood Advances. 8 (2024) 4 - p. 927-935 , 2024

Link: https://doi.org/10.1182/..

10

Real-world Effectiveness of Azacitidine in Treatment-Naive ..:

Rajakumaraswamy, Nishanthan ; Gandhi, Mitul ; Wei, Andrew H....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 4 - p. 260-268.e2 , 2024

Link: https://doi.org/10.1016/..

11

Combination therapy with novel agents for acute myeloid leu..:

Jen, Wei‐Ying ; Kantarjian, Hagop ; Kadia, Tapan M....
British Journal of Haematology. 205 (2024) 1 - p. 30-47 , 2024

Link: https://doi.org/10.1111/..

12

Oral decitabine plus cedazuridine and venetoclax in patient..:

Bataller, Alex ; Montalban-Bravo, Guillermo ; Bazinet, Alexandre...
The Lancet Haematology. 11 (2024) 3 - p. e186-e195 , 2024

Link: https://doi.org/10.1016/..

13

Targetable genetic abnormalities in patients with acute mye..:

Bataller, Alex ; DiNardo, Courtney D. ; Bazinet, Alexandre...
American Journal of Hematology. 99 (2024) 4 - p. 792-796 , 2024

Link: https://doi.org/10.1002/..

14

Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Ph..:

Konopleva, Marina Y. ; Dail, Monique ; Daver, Naval G....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 364-374 , 2024

Link: https://doi.org/10.1016/..

15

Response patterns and impact of MRD in patients with IDH1/2..:

Hammond, Danielle ; Loghavi, Sanam ; Wang, Sa A....
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..